The Clinical Meaning of Benign Colon Uptake in 18F-FDG PET: Comparison with Colonoscopic Findings
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: Benign colon 18F-fluorodeoxyglucose (FDG) uptake is frequently observed in asymptomatic individuals. Aims of this study were to investigate the benign colon uptake by whole body FDG-positron emission tomography (PET) in asymptomatic adults and to correlate those results with colonoscopic and histologic findings. Methods: Among 3,540 subjects who had undergone FDG-PET, 43 subjects who were diagnosed to have benign colon uptake in FDG-PET and underwent colonoscopy were retrospectively reviewed. Subjects were classified as diffuse or focal groups based on their FDG uptake patterns. PET results were analyzed together with colonoscopic and histologic findings. Results: Forty-three subjects showed benign colon uptake in FDG-PET; 28 of them were shown as the diffuse group, while other 15 subjects were classified as the focal group. Five subjects among those showed diffuse uptake were diagnosed as adenoma. Seven among 15 subjects who showed focal uptake were diagnosed as adenocarcinoma (n=2), adenoma (n=3), or non-neoplastic polyp (n=2). Positive predictive values were 25% in the diffuse group and 47% in the focal group. Conclusions: We recommend that patients showing benign FDG uptake in the colon should be further evaluated by colonoscopy, especially for patients with focal FDG uptake.
Abstract
Background/Aims: Benign colon 18F-fluorodeoxyglucose (FDG) uptake is frequently observed in asymptomatic individuals. Aims of this study were to investigate the benign colon uptake by whole body FDG-positron emission tomography (PET) in asymptomatic adults and to correlate those results with colonoscopic and histologic findings. Methods: Among 3,540 subjects who had undergone FDG-PET, 43 subjects who were diagnosed to have benign colon uptake in FDG-PET and underwent colonoscopy were retrospectively reviewed. Subjects were classified as diffuse or focal groups based on their FDG uptake patterns. PET results were analyzed together with colonoscopic and histologic findings. Results: Forty-three subjects showed benign colon uptake in FDG-PET; 28 of them were shown as the diffuse group, while other 15 subjects were classified as the focal group. Five subjects among those showed diffuse uptake were diagnosed as adenoma. Seven among 15 subjects who showed focal uptake were diagnosed as adenocarcinoma (n=2), adenoma (n=3), or non-neoplastic polyp (n=2). Positive predictive values were 25% in the diffuse group and 47% in the focal group. Conclusions: We recommend that patients showing benign FDG uptake in the colon should be further evaluated by colonoscopy, especially for patients with focal FDG uptake.
참고문헌 (19)
- "Goyang: National Cancer Information Center" (2011)[URL]
- Kantorová I, "Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making", J Nucl Med, 44, pp.1784~1788 (2003)
- Israel O, "PET", CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance, 2005, pp.46, 758~762
- Jadvar H, "Effect of atropine and sincalide on the intestinal uptake of F-18 fluorodeoxyglucose", Clin Nucl Med, 24, pp.965~967 (1999)
- Abdel-Nabi H, "Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings", Radiology, 206, pp.755~760 (1998)
- Keogan MT, "Coleman RE. Local recurrence of rectal cancer: evaluation with F-18 fluorodeoxyglucose PET imaging", Abdom Imaging, 22, pp.332~337 (1997)
- Huebner RH, "A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer", J Nucl Med, 41, pp.1177~1189 (2000)
- Falk PM, "Positron emission tomography for preoperative staging of colorectal carcinoma", Dis Colon Rectum, 37, pp.153~156 (1994)
- Gutman F, "Incidental colonic focal lesions detected by FDG PET", CT, 2005, pp.185, 495~500
- Kamel EM, "Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET", CT: correlation with endoscopic and histopathologic results, 2004, pp.45, 1804~1810
- Prabhakar HB, "Bowel hot spots at PET-CT", Radiographics, 27, pp.145~159 (2007)
- Ahmad Sarji S, "Physiological uptake in FDG PET simulating disease", Biomed Imaging Interv J, 2, pp.59~ (2006)
- Tatlidil R, "Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings", Radiology, 224, pp.783~787 (2002)
- Kresnik E, "F-18 fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory bowel disease", Clin Nucl Med, 26, pp.867~ (2001)
- Chen YK, "Colorectal cancer screening in asymptomatic adults: the role of FDG PET scan", Anticancer Res, 23, pp.4357~4361 (2003)
- Pandit-Taskar N, "Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET", AJR Am J Roentgenol, 183, pp.1143~1147 (2004)
- Strauss LG, "Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection?", Eur J Nucl Med Mol Imaging, 34, pp.868~877 (2007)
- Weston BR, "Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center", Cancer, 116, pp.1454~1461 (2010)
- Isobe K, "The role of positron emission tomography in the detection of incidental gastrointestinal tract lesions in patients examined for lung cancer", Nihon Kokyuki Gakkai Zasshi, 48, pp.482~487 (2010)